MedTrace Logo

EXploratory Study on Postprandial Energy Metabolism

NCT06786052 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-05-09

No results posted yet for this study

Summary

This exploratory, double-blinded clinical trial on 66 randomized adults aged 50 to 70 years with moderate overweight or obesity but considered metabolically healthy will consist of comparing metabolic and microbiota parameters before and after 3 months of consumption of a probiotic or a placebo.

Conditions

  • Obesity and Overweight
  • Moderately Obese

Interventions

DIETARY_SUPPLEMENT

Probiotic

After randomization, participants will consume the probiotic for 3 months.

DIETARY_SUPPLEMENT

Placebo

After randomization, participants will consume the placebo for 3 months.

Sponsors & Collaborators

  • Centre de recherche en nutrition humaine de Rhône-Alpes

    collaborator UNKNOWN

  • Lallemand Health Solutions

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-07
Primary Completion
2028-02-29
Completion
2028-02-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06786052 on ClinicalTrials.gov